Whether You’re New to Medical Cannabis or Continuing Your Patient Journey
The medical cannabis patient journey requires informed decisions and ongoing support. Whether you're new or continuing, understanding this journey is essential. This article highlights key aspects of the medical cannabis patient journey.
Deschutes County Commissioners Urge Families to Learn About Cannabis Risks
Public health messaging cannabis risks is critical for guiding families and clinicians. Deschutes County Commissioners urge education on cannabis safety. Evidence-based communication supports informed decisions.
CBD & Cancer: The COM-Scale Scientific Evidence Project by Krisztian Smith – Indiegogo
Crowdfunded cannabis research projects focusing on CBD and cancer are gaining attention but often lack rigorous scientific oversight. This article reviews the COM-Scale Scientific Evidence Project by Krisztian Smith. Clinicians should carefully evaluate…
What the Evidence Actually Says About Cannabis: Risks, Benefits, and Lingering Uncertainties
This cannabis health effects review provides clinicians with evidence-based insights on the risks and benefits of cannabis use. It offers a framework for patient counseling grounded in current research. Understanding these effects helps guide informed…
Cannabinoid Clinical Evidence and Its Role in Chronic Pain Management
Current cannabinoid clinical evidence shows modest benefits primarily for neuropathic pain in chronic pain management. The evidence base remains thin with ongoing research gaps. Understanding this cannabinoid clinical evidence is essential for informed…
Investigating Cannabis Compounds: Clinical Relevance and Research Insights
This article highlights cannabis compounds clinical relevance in ongoing research. Emerging findings emphasize the need for evidence-based medicine. Patient education remains a priority in understanding these compounds.
Marijuana Rescheduling Countdown: Why the “Order of Operations” and Todd Blanche’s Role Matter
The marijuana rescheduling countdown highlights critical regulatory changes that could accelerate clinical trial timelines. This shift aims to remove barriers delaying Phase II and III studies, enabling better evidence-based cannabis therapies.…
The New Marketing Playbook: Lessons From Pharma, Cannabis And Politics – Forbes
Marketing practices in cannabis directly impact clinical care by shaping patient expectations and product choices. Understanding these strategies helps clinicians navigate therapeutic outcomes effectively. This article explores parallels between…
Market Edge | ANC (8 April 2026) – YouTube Video Overview
The Market Edge ANC 8 April 2026 update highlights notable clinical interest in cannabis news. This video provides emerging findings worth monitoring closely. Clinical relevance is assessed cautiously without direct content access.
Grant R16GM146679 Research Foundation Of The City University Of New York
NIH cannabis research funding represents a critical shift toward evidence-based medicine in this field. Grants like R16GM146679 help build research infrastructure at institutions like the City University of New York. This federal investment supports…